Conquering the Complexities of AAV Manufacturing: Advances in Efficiency, Scalability, Compliance: CDMOs/CROs are making progress in removing traditional production bottlenecks to AAV-based gene therapies

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)48-51
Number of pages4
JournalGenetic Engineering and Biotechnology News
Volume45
Issue number5
DOIs
StatePublished - May 1 2025

Cite this